title: Protease inhibitors and rifabutin: isn't the jury still out?
authors.forename: E R
authors.initials: ER
authors.lastname: Jenny-Avital
mesh_terms: D000904:Antibiotics, Antitubercular / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D011480:Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D017828:Rifabutin / Q000627:therapeutic use*; D017211:Treatment Failure; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy*
chemical_list: D000904:Antibiotics, Antitubercular; D011480:Protease Inhibitors; D017828:Rifabutin